Ignite Creation Date:
2024-07-17 @ 11:06 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06470841
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-24
First Post:
2024-06-17
Brief Title:
CHG Combined With Venetoclax and Azacytidine in Newly Diagnosed AML
Sponsor:
Navy General Hospital Beijing
Organization:
Navy General Hospital Beijing
Organization Data
Organization:
Navy General Hospital Beijing
Class:
OTHER
Study ID:
WATCH2023
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Navy General Hospital Beijing
Lead Sponsor Class:
OTHER
Responsible Party:
Liren Qian
Responsible Party Title:
Vice Director
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Navy General Hospital Beijing
Old Name:
None
Old Organization:
None